Navigation Links
Clinician Reports Fast Healing of Intractable Wounds Using MEDIHONEY(R)
Date:4/29/2009

Jason Hanft of Baptist Health South Florida Reports on 11 Patients at SAWC

PRINCETON, N.J., April 29 /PRNewswire-FirstCall/ -- Derma Sciences (OTC Bulletin Board: DSCI), a provider of advanced wound care products, announced that yesterday at the annual Symposium on the Advances in Wound Care (SAWC) in Dallas, Jason R. Hanft, DPM, Director of Medical Education at Baptist Health South Florida, revealed details of a recently concluded 11-patient venous leg ulcer (VLU) case series involving the use of Derma Sciences' MEDIHONEY(R). Dr. Hanft's presentation was part of the general agenda of the conference, where 24 out of 370 abstracts were selected for oral presentation. In addition, 6 other abstracts dealing with MEDIHONEY were presented at SAWC. SAWC is the largest gathering of multidisciplinary wound-care clinicians in the United States.

The study was a confirmatory case series following a positive large 108-patient randomized controlled study published in 2008 on a similar patient population, all of whom suffered from non-healing VLUs, a particularly painful and difficult-to-heal chronic wound. In the recent case series, 11 patients were enrolled with VLUs that had not healed with other advanced wound care modalities - including the gold standard multi-layered compression, as well as silver antimicrobial dressings, hyperbaric oxygen therapy, and antibiotic therapy - for at least 4 months' duration. The study was designed to measure the percentage of wounds that healed in the standard timeframe of 12 weeks, but all 11 wounds healed within 6 weeks, with over half healing within 4 weeks.

According to Dr Hanft, "As renewed interest in the use of sterile, medical-grade honey to achieve wound closure increases, justified by increased scientific and clinical data, the healing potential of MEDIHONEY may
'/>"/>

SOURCE Derma Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Alegent Health Sees Positive Results From Recent Clinician Usability Study Collaboration With Siemens and Motion Computing
2. Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 First Quarter Results
3. Human Genome Sciences Reports Positive Late-Breaker Results at EASL from ACHIEVE Phase 3 Trials of Albuferon(R) in Patients with Chronic Hepatitis C
4. An Independent Study Reports on the Utility of ImmuKnow(R), the Cylex(TM) Immune Cell Function Assay, for Monitoring Heart Transplant Recipients
5. InterMune Reports Presentation of Triple Combination Study of ITMN-191 at European Association for the Study of the Liver (EASL)
6. Addrenex Pharmaceuticals Reports Positive Results in Second Phase 3 Study of ADHD Medication
7. Peregrine Pharmaceuticals Reports Positive Preliminary Data From Phase II Bavituximab Lung Cancer Trial
8. Cardium Reports on Applicability of Corgentin to Stem Cell Therapies: Independent Studies Indicate that Ad5IGF-1 Potentiates Stem Cells to Improve Cardiac Function After Heart Attack
9. Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results and Provides a Corporate Update
10. DURECT Reports Positive Phase IIb Data from TRANSDU(TM)-Sufentanil Clinical Program
11. ExonHit Reports Proof-of-Concept in Breast Cancer Diagnostic Using its SpliceArray(TM) Platform

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)..., Dec. 1 The new position of Execu...ip Biotechnologies, Inc. has been taken up by Howa... more than 30 years of experience creating and man...stein will direct Microchip Biotechnologies, marke...vice operations as the company makes the transitio...
(Date:12/1/2009)...1 CCS Medical, Inc. a leading dire... announced that it has received approval from the ...aware (the "Court") for its bidding procedures in ... substantially all of its assets. ,, Pursuant t...oved bidding procedures for the sale of substantia...
(Date:12/1/2009)...swire-FirstCall/ -- CryoLife, Inc. ( CRY) , an im...ular tissue processing company, announced its init... expects total revenues for the full year of 2010 ...hich includes between $1.5 million and $2.5 millio...of Defense in connection with the development of B...
Breaking Medicine Technology:Howard Goldstein Joins Microchip Biotechnologies, Inc. as Executive Vice President 2CCS Medical Wins Approval from Bankruptcy Court for Its Chapter 11 Asset Sale Bidding Procedures 2CryoLife Provides Initial 2010 Financial Guidance 2CryoLife Provides Initial 2010 Financial Guidance 3CryoLife Provides Initial 2010 Financial Guidance 4CryoLife Provides Initial 2010 Financial Guidance 5Global sunscreen wont save corals 8863 1Global sunscreen wont save corals 8863 2Spinal Decompression Therapy Offers Hope for Back Pain 49093 1Spinal Decompression Therapy Offers Hope for Back Pain 49093 2Potential for noninvasive brain tumor treatment 49089 1Potential for noninvasive brain tumor treatment 49089 2
(Date:12/2/2009)...HICAGO, Dec. 2 Results ... the annual meeting of the Radiological Society of...dence of the benefit of annual screening ultrasoun... risk for breast cancer. In addition, the study co...early breast cancer. ,, "We found that annual s...
(Date:12/2/2009)...rgeted breast ultrasound of suspicious areas of th... cost-effective alternative to invasive biopsies f...f two studies presented today at the annual meetin...NA). , "By performing high-quality breast ultras...oidable invasive diagnostic procedures in young wo...
(Date:12/1/2009)..., NEW YORK, Dec. 1 Reportlinker...s available in its catalogue: ,, Global In Vit...15 ,, http://www.reportlinker.com/p0166596/Gl...casts-to-2015.html ,, Global In Vitro Diagnost...ummary ,, GlobalData,s "Global In Vitro Diagno...
(Date:12/1/2009)...SHINGTON, Dec. 1 The Ke...inic in Los Angeles, has agreed to pay the United ...ceived illegal kickbacks from HealthSouth Corporat...,, The settlement resolves allegations that Hea... of stock option grants, donations to the Kerlan J...
(Date:12/1/2009)...eta is increasingly common but more easily identif...althDay News) -- A magnetic resonance imaging tes...ing pregnancy complication called placenta accreta...en the placenta surrounding a fetus attaches too d...acenta can pull out parts of the uterine wall, rup...
Breaking Medicine News(10 mins):Health News:Annual Screening With Breast Ultrasound or MRI Could Benefit Some Women 2Health News:Annual Screening With Breast Ultrasound or MRI Could Benefit Some Women 3Health News:Targeted breast ultrasound can reduce biopsies for women under 40 2Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 2Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 3Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 4Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 5Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 6Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 7Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 8Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 9Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 10Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 11Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 12Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 13Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 14Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 15Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 16Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 17Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 18Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 19Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 20Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 21Health News:Los Angeles' Kerlan Jobe Orthopaedic Clinic Pays $3 Million to Settle Kickback Allegations 2Health News:Serious Pregnancy Complication Detected With MRI 2
...ali Pharma, an emerging pharmaceutical company spe...s of its pivotal phase III clinical trial positive...acia(R) in children suffering from Vernal Keratoco... form of chronic allergic conjunctivitis character...
...November 18th to 22nd, 2007, under the responsibil...opole(R) is organizing an advanced course on stem ...t exploring the latest advancements of research in...and organ stem cells and cloning. Stem cel...
... Diagnostics today announces that it has completed...ger agreement with BioVeris for approximately $600...he Diagnostics now owns the patents for Electroche...ences research, life science development, patient ...
...y 100 people have been bitten and injured by a jac...o anti-rabies vaccines in the government hospitals...days, the jackal has attacked and injured villager...e being treated at different hospitals in Gopalgan...
...an refugees plan to introduce organic farming in I...pilot organic village will be set up in each of th...India," said Ngodup Dorje, head of the agriculture...sion ranging from training programmes and exposure...
...report on drugs has officially declared Britain th... a Daily Mail report, over 900,000 Britons buy coc...as the biggest user in the continent. In addition,...so said that successful law and order campaigns to...
Other Medicine News:Health News:Novagali Pharma Presents Phase III Clinical Trial of Vekacia(R) for Vernal Keratoconjunctivitis 2Health News:Novagali Pharma Presents Phase III Clinical Trial of Vekacia(R) for Vernal Keratoconjunctivitis 3
...nsive hemodynamic monitoring and information manag...raphics, clinical hemodynamic data, hemodynamic wa... all flow seamlessly into one complete cardiac pat...Both images and information are accessible on a si...
EXXCEL™ Soft Vascular Graft
...um is intended for monitoring the accuracy and pre... It is for in vitro diagnostic use only. Provided ...rs up to ten days stability at 2 8°C once rec...e with the directions accompanying the assay proce...
AdvancedMD Medical Claims Billing
Medicine Products: